Conmed is to buy the arthroscopy and surgical instruments of Bristol-Myers Squibb's Zimmer division for $370 million in cash. Conmed will acquire the Linvatec business, assets relating to Linvatec's international business and Hall Surgical. In addition, Bristol-Myers will receive a 10-year warrant to purchase one million Conmed shares at 130% of its 15-day average price.
Bristol-Myers announced its intention to sell the two business areas in the summer (see Clinica No 767, p 11). The...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?